Street Calls of the Week
Paula Green, SVP of Human Resources at Twist Bioscience Corp (NASDAQ:TWST), sold 295 shares of common stock on September 22, 2025, at a price of $27.56, for a total transaction value of $8130. The transaction occurs as the stock trades near its 52-week low of $24.07, with InvestingPro analysis showing the company maintains a strong balance sheet with a healthy current ratio of 3.9x. Following the transaction, Green directly owns 124,542 shares of Twist Bioscience, a company currently valued at $1.6 billion. According to InvestingPro’s Fair Value model, the stock appears fairly valued, with 12 additional exclusive insights available to subscribers.
In other recent news, Twist Bioscience reported a notable 18% increase in revenue for Q3 2025, reaching $96.1 million. Despite the revenue growth, the company experienced an adjusted EBITDA loss of $8 million, though this was an improvement compared to the previous fiscal year. JPMorgan has adjusted its price target for Twist Bioscience to $25, maintaining an Underweight rating. TD Cowen also lowered its price target to $36, while keeping a Buy rating, citing changes in fiscal year 2025 guidance due to a shift in Next-Generation Sequencing revenue. Evercore ISI reduced its price target to $46, maintaining an Outperform rating, following strong performance in the next-generation sequencing segment. Additionally, Twist Bioscience announced the appointment of Trynka Shineman Blake to its board of directors, where she will serve on the audit committee.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.